Implementation of LUCAS 2 in Helicopter Rescue in South Tyrol

Cardiopulmonary resuscitation (CPR) is used to maintain adequate perfusion of vital organs in cardiac arrest patients and is fundamental for the neurological outcome and survival of these individuals. Unfortunately, the quality of CPR may be inadequate due largely to ineffective chest compressions resulting from rescuer fatigue and interruptions in compressions. The LUCAS device (Lund University Cardiopulmonary Assist System, Jolife, Lund, Sweden), introduced in 2002, is the most extensively tested and applied automated alternative to manual CPR for in-hospital care of cardiac arrest patients and during ambulance transfer; the feasibility of application of this device in helicopter emergency medical service (HEMS) operations, however, has never been addressed. The objective of this project is to equip the three active rescue helicopters in South Tyrol with the LUCAS 2 mechanical chest compression device to answer the question: What is the feasibility and efficiency of using this device for prolonged CPR in cardiac arrest patients requiring CPR during HEMS rescue operations and transport?

Study Overview

Status

Completed

Conditions

Detailed Description

This is a non-controlled, observational study. Physiological endpoints: MAP (mean arterial pressure); etCO2 (end-tidal expiratory pCO2); ROSC (return of spontaneous circulation); PaO2 (arterial pO2); PaCO2 (arterial pCO2); endpoints to assess feasibility: time from arrival to start of mechanical compressions, problems during transfer into the helicopter and in-field manoeuvers, problems with application of device, problems with patient transfer to hospital premises, hands-off time, personnel requirements.

Study Type

Observational

Enrollment (Actual)

18

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • BZ
      • Bolzano, BZ, Italy, 39100
        • Eurac Research

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients in cardiac arrest from all causes requiring CPR

Description

Inclusion Criteria:

  • cardiac arrest with indication of CPR
  • informed consent for those regaining legal competence

Exclusion Criteria:

  • declaration of death on site
  • contraindications of using the device
  • age <18 y

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
CPR
MECHANICAL CHEST COMPRESSION
Other Names:
  • LUCAS2

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Time from arrival of rescue team to start of mechanical compressions
Time Frame: assessed immediatly after the operation is concluded
assessed immediatly after the operation is concluded
Presence of abdominal or thoracic lesions caused by automated chest compressor
Time Frame: Assessed at clinical examination during hospital stay (day 1 to day 30) or autopsy
Assessed at clinical examination during hospital stay (day 1 to day 30) or autopsy

Secondary Outcome Measures

Outcome Measure
Time Frame
Mean arterial pressure
Time Frame: At hospital arrival (expected between 5 minutes and 1 hour from start CPR)
At hospital arrival (expected between 5 minutes and 1 hour from start CPR)
End-tidal expiratory pCO2
Time Frame: At hospital arrival (expected between 5 minutes and 1 hour from start CPR)
At hospital arrival (expected between 5 minutes and 1 hour from start CPR)
Return of spontaneous circulation
Time Frame: Could be each moment during CPR
Could be each moment during CPR
Arterial pO2
Time Frame: At hospital arrival (expected between 5 minutes and 1 hour from start CPR)
At hospital arrival (expected between 5 minutes and 1 hour from start CPR)
Arterial pCO2
Time Frame: At hospital arrival (expected between 5 minutes and 1 hour from start CPR)
At hospital arrival (expected between 5 minutes and 1 hour from start CPR)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Hermann Brugger, Prof, Institute of Mountain Emergency Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2013

Primary Completion (Actual)

March 1, 2016

Study Completion (Actual)

March 1, 2016

Study Registration Dates

First Submitted

December 5, 2012

First Submitted That Met QC Criteria

December 6, 2012

First Posted (Estimate)

December 10, 2012

Study Record Updates

Last Update Posted (Actual)

July 24, 2019

Last Update Submitted That Met QC Criteria

July 22, 2019

Last Verified

July 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • V/15/11

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiac Arrest

Clinical Trials on MECHANICAL CHEST COMPRESSION

Subscribe